Mitsubishi UFJ Trust & Banking Corp Has $18.65 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Mitsubishi UFJ Trust & Banking Corp reduced its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 31,372 shares of the biotechnology company’s stock after selling 1,010 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in Axon Enterprise were worth $18,645,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in AXON. Public Sector Pension Investment Board increased its position in Axon Enterprise by 19.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after acquiring an additional 500 shares during the period. Friedenthal Financial grew its stake in shares of Axon Enterprise by 961.7% in the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after purchasing an additional 1,231 shares during the last quarter. Principal Financial Group Inc. increased its holdings in Axon Enterprise by 33.1% in the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock valued at $54,466,000 after purchasing an additional 33,869 shares during the period. XTX Topco Ltd raised its position in Axon Enterprise by 20.6% during the 3rd quarter. XTX Topco Ltd now owns 5,650 shares of the biotechnology company’s stock worth $2,258,000 after purchasing an additional 964 shares during the last quarter. Finally, Artemis Investment Management LLP lifted its holdings in Axon Enterprise by 21.4% during the 4th quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company’s stock worth $56,528,000 after buying an additional 16,792 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is owned by insiders.

Axon Enterprise Stock Down 1.5 %

Shares of NASDAQ:AXON opened at $550.65 on Friday. The business’s 50 day simple moving average is $590.80 and its two-hundred day simple moving average is $546.79. The firm has a market cap of $42.19 billion, a P/E ratio of 142.29, a PEG ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Barclays reissued a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. TD Cowen started coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price on the stock. Finally, Needham & Company LLC reiterated a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a report on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.